
Home » Prescription Drugs 6 » Diprosone Ointment Generic Betamethasone Dipropionate
DIPROSONE is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. These include atopic eczema infantile eczema nummular eczema contact dermatitis neurodermatitis anogenital and senile pruritus lichen planus intertrigo and psoriasis.DIPROSONE Cream and Ointment: Apply a small amount to the affected area twice daily. For some patients adequate maintenance therapy may be achieved with once daily application.In most cases 4 weeks continuous treatment should be considered the maximum.Children: Administration of topical corticosteroids to children should be limited to the least amount compatible with an effective therapeutic regimen.
Buy Diprosone Ointment Generic Betamethasone Dipropionate and other Prescription Drugs 6 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Diprosone Ointment Generic Betamethasone Dipropionate:
Product Type: Prescription Drugs 6
Diprosone Ointment (Generic Betamethasone Dipropionate)
Diprosone Ointment (Generic Betamethasone Dipropionate)
Generic Betamethasone Dipropionate
0.05%w/w 15gm 50gm
Generic Betamethasone Dipropionate Diprosone Ointment

View more
Prescription Drugs 6
Previous Product Next Product
Pharmacy:
Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide:
Which drugs are scheduled to go generic?
Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.


|